Exploring efficient and effective mammalian models for Alzheimer’s disease

Exploring efficient and effective mammalian models for Alzheimer’s disease

The aim of this study was to explore and discuss efficient and effective mammalian models for Alzheimer’s disease (AD). In this study, efficient AD models are characterized by a small body size, a short lifespan, and rapid development of the main pathology including amyloid plaque formation. Effecti...

Full description

Saved in:

Bibliographic Details
Main Author:	Mitsunori Kayano
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	amyloid-β α-synuclein blood brain barrier cerebral amyloid angiopathy marmoset dog
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2025.1652754/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage
by: Philipp Arndt, et al.
Published: (2025-08-01)

Neuropathological Correlates of White Matter Hyperintensities in Cerebral Amyloid Angiopathy
by: Nazanin Makkinejad, et al.
Published: (2024-11-01)

Modulation of Rage and CD147 in Cerebral Amyloid Angiopathy <i>in vitro</i>
by: A. I. Mosiagina, et al.
Published: (2022-05-01)

Cerebral inflammatory amyloid angiopathy: response to treatment
by: João Roberto Ribeiro Pimenta, et al.
Published: (2025-08-01)

Cerebral hemorrhage due to amyloid angiopathy that was difficult to differentiate from breast cancer metastasis: a case report
by: Toshitaka Uomori, et al.
Published: (2021-06-01)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
by: Xiang‐Sha Yin, et al.
Published: (2025-04-01)

Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study
by: Md Tahmid Yasar, et al.
Published: (2025-06-01)

Convexity subarachnoid hemorrhage: clinical features and etiology of an Argentinian cohort
by: Aníbal Chertcoff, et al.

Enhanced Blood‐Brain Barrier Penetrability of BACE1 SiRNA‐Loaded Prussian Blue Nanocomplexes for Alzheimer's Disease Synergy Therapy
by: Xiaoyuan Ding, et al.
Published: (2025-08-01)

Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features—An Update
by: Stefan Weidauer, et al.
Published: (2025-03-01)

Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein
by: Jingfeng Liang, et al.
Published: (2025-08-01)

A splice‐switching antisense oligonucleotide targeting APP reduces accumulation of α‐synuclein in a mouse model of Parkinson's disease
by: Rijwan U. Ahammad, et al.
Published: (2025-04-01)

RETRACTED ARTICLE: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
by: Cassia R Overk, et al.
Published: (2014-05-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Cortical thickness and structural covariance network alterations in cerebral amyloid angiopathy: A graph theoretical analysis
by: Yijun Lin, et al.
Published: (2025-06-01)

Head to head comparison of two PET/CT imaging agents, [18F]D3FSP ([18F]P16-129) and [18F]AV45, in patients with alzheimer’s disease
by: David Alexoff, et al.
Published: (2025-06-01)

Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors
by: Maricarmen Hernández-Rodríguez, et al.
Published: (2025-03-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy
by: Yanyan Xu, et al.
Published: (2025-06-01)

Integrative in silico and in vitro analysis of Pinus roxburghii essential oil: unveiling its antioxidant, antidiabetic, and antiglycation potential
by: Rubina Naz Qaisrani, et al.
Published: (2025-04-01)

Relationship between cerebral small vessel disease and proteinopathies in the medial temporal lobe
by: Valentina Perosa, et al.
Published: (2025-07-01)

Traumatic Brain Injury and Genetic Risk for Alzheimer’s Disease Impact Cerebrospinal Fluid β-Amyloid Levels in Vietnam War Veterans
by: Jena N. Moody, et al.
Published: (2024-11-01)

Amyloid blood biomarker detects Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2018-04-01)

Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer’s disease in a tertiary memory clinic
by: Javier Arranz, et al.
Published: (2025-07-01)

The role of monocytes and macrophages in the progression of Alzheimer’s disease
by: Wenyi Nie, et al.
Published: (2025-04-01)

Nasal Aβ42 mirrors brain amyloid dynamics and cognitive decline across the Alzheimer’s disease continuum
by: Da Hae Jung, et al.
Published: (2025-08-01)

No evidence of Alzheimer’s disease pathology in mice infected with Toxocara canis
by: Vosála Ondřej, et al.
Published: (2025-01-01)

Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model
by: Ting-Ting Pan, et al.
Published: (2025-08-01)

The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential
by: Joanna Kruszka, et al.
Published: (2025-05-01)

Chaperone-Mediated Responses and Mitochondrial–Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer’s Disease
by: Manish Kumar Singh, et al.
Published: (2025-07-01)

Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
by: Kiwami Kidana, et al.
Published: (2018-01-01)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-09-01)

Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns
by: Luisa Knecht, et al.
Published: (2024-12-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01)

Cell-specific Nav1.6 knockdown reduced astrocyte-derived Aβ by reverse Na+-Ca2+ transporter-mediated autophagy in alzheimer-like mice
by: Xin Wang, et al.
Published: (2025-06-01)

Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
by: Chenyu Zhuang, et al.
Published: (2025-03-01)

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
by: I. A. Mazerkina
Published: (2025-04-01)

Dietary supplements for prevention of Alzheimer’s disease: In vivo and in silico molecular docking studies
by: Doha Mohamed, et al.
Published: (2025-02-01)

Alzheimer’s Disease: The Impact of Gut Microbiota and Sex Differences on Pathogenesis and Treatment Strategies
by: Kh. A. Abdel-Sater
Published: (2025-05-01)

Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application
by: Nandhini Jayaprakash, et al.
Published: (2025-06-01)